HLVX
HilleVax, Inc. - Common Stock (HLVX)
$10
About HilleVax, Inc. - Common Stock (HLVX)
HilleVax, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel vaccines. Its pipeline includes Norovirus and HIL-214. The company was founded by Maurice Hilleman and Tadataka Yamada on March 25, 2020 and is headquartered in Boston, MA.
Details
Daily high
$2.12
Daily low
$2.02
Price at open
--
52 Week High
$2.15
52 Week Low
$1.34
Market cap
105.3M
Dividend yield
0.00%
Volume
610
Avg. volume
466,514
P/E ratio
-.97
HilleVax, Inc. - Common Stock News
Details
Daily high
$2.12
Daily low
$2.02
Price at open
--
52 Week High
$2.15
52 Week Low
$1.34
Market cap
105.3M
Dividend yield
0.00%
Volume
610
Avg. volume
466,514
P/E ratio
-.97